Viromed Medical AGXTER:VME -2.11%22 Current Ratio is 2.74 as of Dec. 2025, which is 41% above its 10-year median of 1.94. GuruFocus rates XTER:VME with a GF Score™ of 22/100. The stock has 5 warning signs investors should review. Among 854 Medical Devices & Instruments companies, Viromed Medical AG ranks better than 54.57% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Viromed Medical AG's current ratio for the quarter that ended in Dec. 2025 was 2.74.
Viromed Medical AG has a current ratio of 2.74. It generally indicates good short-term financial strength.
The historical rank and industry rank for Viromed Medical AG's Current Ratio or its related term are showing as below:
XTER:VME'
s Current Ratio Range Over the Past 10 Years
Min: 1.08 Med: 1.94 Max: 3.27
Current: 2.74
During the past 5 years, Viromed Medical AG's highest Current Ratio was 3.27. The lowest was 1.08. And the median was 1.94.
XTER:VME's Current Ratio is ranked better than 54.57% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: 2.475
vs XTER:VME: 2.74
Viromed Medical AG (XTER:VME) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Viromed Medical AG Current Ratio Related Terms
Viromed Medical AG Current Ratio Historical Data
* Premium members only.
The historical data trend for Viromed Medical AG's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XTER:VME vs ABT, SYK, MDT: Current Ratio Comparison
For the Medical Devices subindustry, Viromed Medical AG's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Viromed Medical AG Current Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Viromed Medical AG's Current Ratio distribution charts can be found below:
* The bar in red indicates where Viromed Medical AG's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Viromed Medical AG (XTER:VME) has a Current Ratio of 2.74 as of Dec. 2025. This is 41% above median its historical median of 1.94. Over the past decade, Viromed Medical AG's Current Ratio has ranged from 1.08 to 3.27. According to the industry distribution chart, Viromed Medical AG ranks #388 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 45.4%.
Is Viromed Medical AG's Current Ratio too high?
Viromed Medical AG's current Current Ratio of 2.74 is 41% above median its 10-year median of 1.94. Over the past 10 years, this metric has ranged from a low of 1.08 to a high of 3.27. The Medical Devices & Instruments industry median Current Ratio is 2.48. Viromed Medical AG's value of 2.74 is 10.7% above this industry median. Based on the distribution chart, Viromed Medical AG ranks #388 out of 854 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Viromed Medical AG has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Viromed Medical AG's Current Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Viromed Medical AG ranks #388 out of 854 companies for Current Ratio. This puts Viromed Medical AG in the upper half of its industry. The industry median Current Ratio is 2.48. Viromed Medical AG's value of 2.74 is 10.7% above this benchmark. Historically, Viromed Medical AG's own Current Ratio has ranged from 1.08 to 3.27 over the past decade. While the company's 10-year median is 1.94 vs. the industry median of 2.48, Viromed Medical AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Medical Devices & Instruments company?
The median Current Ratio among Medical Devices & Instruments companies is 2.48, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Viromed Medical AG's current Current Ratio of 2.74 is 10.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median Current Ratio is 2.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Viromed Medical AG's current Current Ratio is 2.74, which is 41% above median its own 10-year median of 1.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Viromed Medical AG stock overvalued right now?
Viromed Medical AG (XTER:VME) has a current Current Ratio of 2.74. The current Current Ratio is 2.74, which is 41% above median its 10-year median of 1.94 and 10.7% above the Medical Devices & Instruments industry median of 2.48. Viromed Medical AG's overall GF Score™ is 22/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Viromed Medical AG (XTER:VME), the current Current Ratio is 2.74 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Viromed Medical AG is a medical technology company. It focuses on using cold plasma technology to develop medical solutions that protect people from viruses, bacteria, and multi-resistant germs. Viromed's product offerings include ViroCAP, a medical device based on cold plasma technology for treating wounds; ViroCAP derma-podo, a medical device that uses cold atmospheric plasma therapy for skin and foot care; and a Raumluftentkeimer. The company covers the entire value chain from research and development to production, logistics, marketing, and sales of its products.
22GF Score
Get the complete analysis for XTER:VME
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTER:VME has been successfully added to your 
